Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02332993 · ClinicalTrials.gov registry record
Nutritional Regulation of Wound Inflammation: Part III
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 22
- Enrollment target
NCT02332993 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 22 participants.
The verdict
NCT02332993 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the changes that result in the wound healing of a type II Diabetic using Negative Pressure Therapy after 12 weeks of daily supplementation of ImmunAge (Fermented Papaya Preparation (FPP). ImmunAge (FPP) is a supplement made from Carica papaya Linn and is available over the counter. ImmunAge (FPP) is an investigational drug, which means it has not been approved by the U. S. Food and Drug Administration (FDA). Approximately 30 subjects will participate in this study. 15 subjects will take the supplementation and 15 subjects to take no supplementation as the control. The
Interventions
- DIETARY_SUPPLEMENT FPP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2014-12 |
| Est. Completion | 2018-02-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02332993
The ClinicalTrials.gov registry entry for NCT02332993 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FPP is the first listed.
NCT02332993 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02332993 about?
NCT02332993 is a clinical study titled "Nutritional Regulation of Wound Inflammation: Part III". The purpose of this study is to examine the changes that result in the wound healing of a type II Diabetic using Negative Pressure Therapy after 12 weeks of daily supplementation of ImmunAge (Fermented Papaya Preparation (FPP). ImmunAge (FPP) is a supplement made from Carica papaya Linn and is avail...
What is the current status of trial NCT02332993?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2014-12. Estimated completion is 2018-02-10.
What interventions are being tested in trial NCT02332993?
The interventions under investigation include: FPP (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02332993?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.